Reiley Pharmaceuticals Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $97.7K

Reiley Pharmaceuticals General Information

Description

Developer of biopharmaceutical products intended to cater to people in San Francisco, California. The company's diagnostic radiopharmaceutical and therapeutic products are designed to treat pain, cancer, and infectious diseases, enabling patients to recover faster.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Drug Discovery
Pharmaceuticals
Corporate Office
  • 3749 Buchanan Street
  • Suite 475745
  • San Francisco, CA 94147
  • United States
+1 (650) 000-0000

Reiley Pharmaceuticals Timeline

2021202220232024
Financing Round

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Reiley Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 04-Jun-2024 $97.7K 00.000 Completed Generating Revenue
5. Later Stage VC 18-Oct-2022 00000 00.000 Completed Generating Revenue
4. Later Stage VC (Series C1) 03-Aug-2020 00.000 00.000 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 07-Nov-2017 00.00 00.000 0000 Completed Generating Revenue
2. Early Stage VC (Series B) 06-Jan-2016 $1.1M $2.08M 00.00 Completed Generating Revenue
1. Early Stage VC (Series A) 29-Aug-2014 $980K $980K 00.000 Completed Generating Revenue
To view Reiley Pharmaceuticals’s complete valuation and funding history, request access »

Reiley Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C-1 0,000,000 00.000000 00.00 00.0 00.0 00 00.0 0.000
Series C 0,000,000 00.000000 00.00 00.0 00.0 00 00.0 0.000
Series B 3,539,853 $0.000100 $0.05 $0.71 $0.71 1x $0.71 14.56%
Series A 2,426,428 $0.000100 $0.04 $0.5 $0.5 1x $0.5 9.98%
To view Reiley Pharmaceuticals’s complete cap table history, request access »

Reiley Pharmaceuticals Patents

Reiley Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021356529-A1 Coxib-derived conjugate compounds and methods of use thereof Pending 07-Oct-2020 000000000
US-20220133918-A1 Coxib-derived conjugate compounds and methods of use thereof Pending 07-Oct-2020 00000000000
CA-3195082-A1 Coxib-derived conjugate compounds and methods of use thereof Pending 07-Oct-2020 000000000
EP-4225384-A1 Coxib-derived conjugate compounds and methods of use thereof Pending 07-Oct-2020 000000000
JP-2023545298-A Complex compounds derived from coxibs and their use Pending 07-Oct-2020 A61P19/02
To view Reiley Pharmaceuticals’s complete patent history, request access »

Reiley Pharmaceuticals Executive Team (2)

Name Title Board Seat Contact Info
Donald Kiepert Chief Executive Officer, Advisor & Board Member
Mark Reiley MD Co-Founder
To view Reiley Pharmaceuticals’s complete executive team members history, request access »

Reiley Pharmaceuticals Board Members (4)

Name Representing Role Since
B. Silber Ph.D Self Board Member 000 0000
Donald Kiepert Reiley Pharmaceuticals Chief Executive Officer, Advisor & Board Member 000 0000
Jeffrey Dunn Self Board Member 000 0000
Keith Valentine Self Board Member 000 0000
To view Reiley Pharmaceuticals’s complete board members history, request access »

Reiley Pharmaceuticals FAQs

  • When was Reiley Pharmaceuticals founded?

    Reiley Pharmaceuticals was founded in 2014.

  • Who is the founder of Reiley Pharmaceuticals?

    Mark Reiley MD is the founder of Reiley Pharmaceuticals.

  • Who is the CEO of Reiley Pharmaceuticals?

    Donald Kiepert is the CEO of Reiley Pharmaceuticals.

  • Where is Reiley Pharmaceuticals headquartered?

    Reiley Pharmaceuticals is headquartered in San Francisco, CA.

  • What industry is Reiley Pharmaceuticals in?

    Reiley Pharmaceuticals’s primary industry is Therapeutic Devices.

  • Is Reiley Pharmaceuticals a private or public company?

    Reiley Pharmaceuticals is a Private company.

  • What is Reiley Pharmaceuticals’s current revenue?

    The current revenue for Reiley Pharmaceuticals is 000000.

  • How much funding has Reiley Pharmaceuticals raised over time?

    Reiley Pharmaceuticals has raised $4.93M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »